17 alpha-hydroxylase deficiency natural history, complications and prognosis: Difference between revisions
(Created page with "__NOTOC__ {{Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency}} {{CMG}}; {{AE}} {{Ammu}} ==Overview== If left untreated, patients with congenital adrenal h...") |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
If left untreated, patients with congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency may progress to develop malignant hypertension. Common complications of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency include muscle weakness, metabolic alkalosis, and azoospermia. Prognosis is generally good with treatment. | If left untreated, patients with congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency may progress to develop [[malignant hypertension]]. Common complications of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency include muscle weakness, [[metabolic alkalosis]], and [[azoospermia]]. Prognosis is generally good with treatment. | ||
==Natural History== | ==Natural History== | ||
If left untreated, patients with congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency may progress to develop malignant hypertension.<ref> Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Wikipedia (2016). https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency Accessed on January 29, 2016</ref> | If left untreated, patients with congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency may progress to develop malignant hypertension.<ref> Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Wikipedia (2016). https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency Accessed on January 29, 2016</ref> |
Revision as of 16:58, 4 February 2016
Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
17 alpha-hydroxylase deficiency natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency natural history, complications and prognosis |
FDA on 17 alpha-hydroxylase deficiency natural history, complications and prognosis |
CDC on 17 alpha-hydroxylase deficiency natural history, complications and prognosis |
17 alpha-hydroxylase deficiency natural history, complications and prognosis in the news |
Blogs on 17 alpha-hydroxylase deficiency natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
If left untreated, patients with congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency may progress to develop malignant hypertension. Common complications of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency include muscle weakness, metabolic alkalosis, and azoospermia. Prognosis is generally good with treatment.
Natural History
If left untreated, patients with congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency may progress to develop malignant hypertension.[1]
Complications
Complications of Hypertension
- Vascular hemorrhage
- Renal insufficiency
- Left ventricular hypertrophy
- Hypertensive retinopathy
- Stroke
Complications of Hypokalemia
- Muscle weakness
- Metabolic alkalosis
- Paralytic ileus
Other Complications
Prognosis
- The prognosis of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency is generally good or excellent.
References
- ↑ Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Wikipedia (2016). https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency Accessed on January 29, 2016